GLENMARK:NSE
Glenmark Pharmaceuticals Ltd
₹2,250.50
arrow_upward
+0.20%(+4.50) 1D
Okt 15, 3:30:00 PM GMT+5:30 · INR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa GLENMARK...
Buksan
₹2,242.00
Mataas
₹2,289.50
Mababa
₹2,241.20
Mkt. cap
635.15B
Avg. na dami
554.25K
Dami
488.52K
Dividend
0.22%
Bawat tatlong buwang dividend
₹1.25
Petsa ng ex-dividend
Okt 3, 2025
P/E ratio
35.34
Mataas nang 52-wk
₹2,537.60
Mababa nang 52-wk
₹1,792.60
EPS
₹63.68
Mga natitirang share
0.00
Bilang ng mga empleyado
17K
Buksan
₹2,242.00
Mataas
₹2,289.50
Mababa
₹2,241.20
Mkt. cap
635.15B
Avg. na dami
554.25K
Dami
488.52K
Dividend
0.22%
Bawat tatlong buwang dividend
₹1.25
Petsa ng ex-dividend
Okt 3, 2025
P/E ratio
35.34
Mataas nang 52-wk
₹2,537.60
Mababa nang 52-wk
₹1,792.60
EPS
₹63.68
Mga natitirang share
0.00
Bilang ng mga empleyado
17K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Bloomberg.com
·
1 araw ang nakalipas
Stocks Fall as AI Rout Spurs Flight to Treasuries: Markets Wrap
MarketWatch
·
1 buwan ang nakalipas
The S&P 500 keeps climbing on days when stocks broadly struggle. Here’s what’s going on.
Reuters
·
1 buwan ang nakalipas
S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
New York Post
·
3 araw ang nakalipas
Wall Street’s big but narrow rally: 4 in 10 S&P stocks are down this year
Profile
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company based in Mumbai. Founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer, it is listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company produces and distributes medicines in more than 80 countries, with operations concentrated in India, North America, Europe, and emerging markets. As of March 2026, it employed approximately 17,000 people. Its name derives from Saldanha's sons, Glenn and Mark. Wikipedia
Tungkol sa Glenmark Pharmaceuticals Ltd